We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Flowserve
FLS
$9.22B
| $35.2M | 0.11% |
667,236
-130,843
| -16% | -$6.43M |
|
302
3M
MMM
$94.3B
| $34.9M | 0.11% |
240,616
-14,591
| -6% | -$2.25M |
|
303
Dentsply Sirona
XRAY
$2.69B
| $34.9M | 0.11% |
597,445
+108,865
| +22% | +$5.85M |
|
304
Quest Diagnostics
DGX
$26.4B
| $34.8M | 0.11% |
341,892
+207,671
| +155% | +$20M |
|
305
J.M. Smucker
SJM
$13.3B
| $34.8M | 0.11% |
302,000
-26,600
| -8% | -$3.25M |
|
306
DexCom
DXCM
$29.3B
| $34.7M | 0.11% |
925,652
-7,464
| -0.8% | -$235K |
|
|
MIME
307
DELISTED
Mimecast Limited
MIME
| $34.2M | 0.11% |
732,743
-4,880
| -0.7% | -$232K |
|
308
Sherwin-Williams
SHW
$86.9B
| $34.2M | 0.11% |
223,875
-600
| -0.3% | -$89.7K |
|
|
FITB
309
Fifth Third Bancorp
FITB
$51.8B
| $34M | 0.11% |
1,218,500
-18,900
| -2% | -$518K |
|
310
WIX.com
WIX
$2.42B
| $33.9M | 0.11% |
238,218
-1,770
| -0.7% | -$239K |
|
311
CarGurus
CARG
$3.19B
| $33.8M | 0.11% |
935,944
+66,135
| +8% | +$2.48M |
|
|
AGN
312
DELISTED
Allergan plc
AGN
| $33.5M | 0.11% |
199,904
-117,440
| -37% | -$16.3M |
|
|
AVLR
313
DELISTED
Avalara, Inc.
AVLR
| $33.5M | 0.11% |
+463,344
| New | +$29.9M |
|
314
Netflix
NFLX
$305B
| $33M | 0.11% |
898,260
-955,440
| -52% | -$34.5M |
|
315
Robert Half
RHI
$4.19B
| $33M | 0.11% |
578,722
-54,700
| -9% | -$3.26M |
|
|
MASI
316
DELISTED
Masimo
MASI
| $32.9M | 0.11% |
220,933
-2,056
| -0.9% | -$282K |
|
317
IBM
IBM
$205B
| $32.6M | 0.11% |
247,261
-1,569
| -0.6% | -$206K |
|
318
Sprouts Farmers Market
SFM
$7.33B
| $32.6M | 0.11% |
1,724,394
-1,266,256
| -42% | -$26.4M |
|
|
STL
319
DELISTED
Sterling Bancorp
STL
| $32.5M | 0.11% |
1,528,198
+165,170
| +12% | +$3.39M |
|
320
Labcorp
LH
$25.6B
| $32.5M | 0.11% |
218,848
+129,255
| +144% | +$18M |
|
321
PG&E
PCG
$40.5B
| $32.5M | 0.11% |
+1,416,000
| New | +$28.5M |
|
322
Globant
GLOB
$1.5B
| $32.2M | 0.1% |
+319,064
| New | +$27.8M |
|
323
Paylocity
PCTY
$7.23B
| $32.2M | 0.1% |
342,743
-138,397
| -29% | -$13.1M |
|
|
AXON
324
Axon Enterprise
AXON
$42.1B
| $32.1M | 0.1% |
500,414
-1,641
| -0.3% | -$107K |
|
|
WRI
325
DELISTED
Weingarten Realty Investors
WRI
| $32.1M | 0.1% |
1,171,026
+556,826
| +91% | +$16M |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.